NLM Selects InTouch for Indexing in the MEDLARS System

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 6
Volume 11
Issue 6

WASHINGTON-InTouch magazine, published by PRR for cancer patients and their family members, has been selected by the US National Library of Medicine (NLM) to be indexed and included in Index Medicus and MEDLINE.

WASHINGTON—InTouch magazine, published by PRR for cancer patients and their family members, has been selected by the US National Library of Medicine (NLM) to be indexed and included in Index Medicus and MEDLINE.

"It’s a real tribute to the editorial quality of InTouch," Steven T. Rosen, MD, said. Dr. Rosen, director of the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, serves as medical editor-in-chief for InTouch, which just celebrated its third year of publication.

The National Library of Medicine looks to an advisory committee—the Literature Selection Technical Review Committee—to choose journals and other publications for citation. Composed of authorities knowledgeable in the field of biomedicine, the committee includes physicians, researchers, educators, editors, health science librarians, and historians who review and recommend titles for indexing.

The databases in the MEDLARS system in which InTouch will appear are Index Medicus and its online counterpart, MEDLINE, the system’s principal online bibliographic citation database. About 4,500 titles are indexed and included in the MEDLINE database, and 3,630 in Index Medicus.

"We’re delighted that the NLM has recognized the integrity and value of the information in InTouch," Dr. Rosen said. "Their endorsement furthers our mission, which is to give patients and their loved ones the most authoritative and up-to-date information on cancer prevention and treatment so that they can be better informed about their health care."

To search MEDLINE, go to PubMed located on the web at www.ncbi.nih.gov/entrez/query.fcgi.  

Recent Videos
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Recent findings presented at ASTRO 2025 suggest an “exciting opportunity” to expand the role of radiation oncology in different non-malignant indications.
The 3 most likely directions of radiotherapy advancements come from new technology, combinations with immunotherapy, and the incorporation of particle therapy.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
4 experts in this video
4 experts in this video
Distance and training represent 2 major obstacles to making radiotherapy available to more patients with cancer across the world.